Purpose:To investigate what effect decreased opioid prescribing following hip arthroscopy had on PresseGaney satisfaction survey scores. Methods: A retrospective review of prospectively collected data was conducted on patients who underwent primary hip arthroscopy for femoroacetabular impingement between October 2014 and October 2019. Inclusion criteria consisted of complete PresseGaney survey information, no history of trauma, fracture, connective tissue disease, developmental hip dysplasia, autoimmune disease, or previous hip arthroscopy. Groups were separated based on date of surgery relative to implementation of an institutional opioid reduction policy that occurred in October 2018. Prescriptions were converted to milligram morphine equivalents (MME) for direct comparison between different opioids. Results: A total of 113 patients met inclusion criteria, 88 preprotocol and 25 postprotocol. There were no statistically significant differences between groups with respect to patient demographics or intraoperative pathologies (P > .05). Average opioid prescription dropped from 249.6 AE 152 MME (equivalent to 33.3 tablets of oxycodone 5 mg) preprotocol to 108.6 AE 84.7 MME (equivalent to 14.5 tablets of oxycodone 5 mg) postprotocol; P ¼ .0002. There were no statistically significant differences in PresseGaney survey scores between pre-and postprotocol groups (P > .05). Conclusions: A reduction in opioids prescribed after a hip arthroscopy is not associated with any statistically significant difference in patient satisfaction with pain management, as measured by the PresseGaney survey. Level of Evidence: Level III, retrospective comparative study.T he opioid epidemic was responsible for more than 46,000 deaths in the United States in 2018. 1 While awareness and advocacy have increased tremendously, there remain many areas for improvement. Orthopaedic surgeons are the third-greatest prescribers of opioids among all specialties and therefore play a significant role in both the cause and the solution to this epidemic. 1 Opioid-based analgesia routinely has been prescribed to manage acute pain after orthopaedic procedures. 2 Overprescription has been linked with physician desire to properly manage patient expectations, along with fear of potential consequences associated with undertreating pain. 3 Existing literature has suggested that overprescribing is linked, at least in part, to a physician desire to mitigate poor patient satisfaction ratings, despite providing otherwise positive health care. [3][4][5] The PresseGaney (PG) survey is a commonly administered patient satisfaction tool that measures patient perception of care, using similar metrics as the Hospital Consumer Assessment of Healthcare Providers and Systems survey, which is used as a reimbursement metric by the Value-Based Purchasing program. 6 These programs place great emphasis on the patient's perception of care, and pain control remains a major metric in this paradigm. 3,4 Previous research by Kohring et al. 7 demonstrated no correlation between PG scor...